Alliance for Pandemic Preparedness
August 28, 2020
Low-Dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
Category: Article Summary
Topic: Testing and Treatment
Keywords (Tags): treatment
- Catteau et al. conducted a retrospective analysis of in-hospital mortality using Belgian national COVID-19 hospital surveillance data (n=8,075) and found that, after adjusting for clinical and demographic features, mortality was lower among patients who received low-dose hydroxychloroquine (2400 mg over 5 days) compared to supportive care alone (HR=0.7, 95%CI: 0.6-0.8).
Catteau et al. (Aug 24, 2020). Low-Dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2020.106144